EA200500313A1 - DISINTOXICATION INFUSION SOLUTION - Google Patents
DISINTOXICATION INFUSION SOLUTIONInfo
- Publication number
- EA200500313A1 EA200500313A1 EA200500313A EA200500313A EA200500313A1 EA 200500313 A1 EA200500313 A1 EA 200500313A1 EA 200500313 A EA200500313 A EA 200500313A EA 200500313 A EA200500313 A EA 200500313A EA 200500313 A1 EA200500313 A1 EA 200500313A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- infusion solution
- detoxification
- biologically active
- liver damage
- components
- Prior art date
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Изобретение относится к медицине, а именно, к многокомпонентным инфузионным растворам, обладающим дезинтоксикационным, гепатопротекторным действием, и может быть использовано при интоксикациях организма различной тяжести, а также при лечении заболеваний, сопровождающихся поражениями печени. Задачей изобретения является создание инфузионного раствора, обладающего повышенной детоксицирующей активностью за счет желчегонного действия и позволяющего эффективно лечить заболевания, сопровождающиеся тяжелыми поражениями печени. Поставленная задача решается тем, что дезинтоксикационный инфузионный раствор, содержащий хлориды натрия, магния и калия, биологически активный компонент - натрия N-метилглюкамина сукцинат, и растворитель - воду для инъекций, дополнительно содержит в качестве биологически активных компонентов рибоксин, метионин и никотинамид, при следующем соотношении компонентов, мас.%:The invention relates to medicine, namely, to multicomponent infusion solutions with detoxification, hepatoprotective effect, and can be used for intoxication of the body of varying severity, as well as in the treatment of diseases involving liver damage. The objective of the invention is the creation of an infusion solution with increased detoxifying activity due to choleretic action and allowing you to effectively treat diseases accompanied by severe liver damage. The problem is solved in that a detoxification infusion solution containing sodium, magnesium and potassium chlorides, a biologically active component — sodium N-methyl glucamine succinate, and a solvent — water for injection, additionally contains riboxin, methionine, and nicotinamide as biologically active components; the ratio of components, wt.%:
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EA200500313A EA007865B1 (en) | 2005-03-01 | 2005-03-01 | Disintoxicating infusion solution |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EA200500313A EA007865B1 (en) | 2005-03-01 | 2005-03-01 | Disintoxicating infusion solution |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| EA200500313A1 true EA200500313A1 (en) | 2006-10-27 |
| EA007865B1 EA007865B1 (en) | 2007-02-27 |
Family
ID=42121412
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EA200500313A EA007865B1 (en) | 2005-03-01 | 2005-03-01 | Disintoxicating infusion solution |
Country Status (1)
| Country | Link |
|---|---|
| EA (1) | EA007865B1 (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2549448C1 (en) * | 2014-05-20 | 2015-04-27 | Екофарм Патент Менеджмент Аг | Balanced infusion solution |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SU601008A1 (en) * | 1976-10-29 | 1978-04-05 | 2-Й Московский Ордена Ленина Государственный Медицинский Институт Им. Н.И. Пирогова | "pirroxan" medication for treating alcoholism |
| AU2330892A (en) * | 1992-07-06 | 1994-01-31 | Natalya Mikhailovna Burbenskaya | Pharmaceutical composition having anti-alcohol, radioprotecting and anti-choleraic activity and stimulating energy metabolism, stomach mucous membrane acid-generation and secretion functions |
| RU2017489C1 (en) * | 1992-10-19 | 1994-08-15 | Росляков Виктор Яковлевич | Medicinal agent for parenteral nutrition and disintoxication |
| EA000879B1 (en) * | 1998-12-02 | 2000-06-26 | Общество С Ограниченной Ответственностью "Научно-Технологическая Фармацевтическая Фирма "Полисан" | Infusion solution ''reamberin'' |
| RU2240116C1 (en) * | 2003-08-20 | 2004-11-20 | Общество С Ограниченной Ответственностью "Научно-Технологическая Фармацевтическая Фирма "Полисан" | Disintoxicating infusion solution |
-
2005
- 2005-03-01 EA EA200500313A patent/EA007865B1/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EA007865B1 (en) | 2007-02-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EA200801492A1 (en) | PHARMACEUTICAL APPLICATION OF SUBSTITUTED AMIDES | |
| BR112014010275A2 (en) | diabetes treatment formulations | |
| EA201300522A1 (en) | PHARMACEUTICAL COMBINATIONS FOR THE TREATMENT OF METABOLIC DISORDERS | |
| NO20064186L (en) | Substituted pyrazoline compositions to reduce blood triglycerides | |
| RU2016147575A (en) | CONTINUOUS INTRODUCTION OF L-DOPA, DOPA-DECARBOXYLASE INHIBITORS, CATHEOL-O-METHYL TRANSFERASE INHIBITORS AND INTENDED FOR THIS COMPOSITION | |
| EA201290078A1 (en) | HETEROCYCLIC COMPOUNDS TO INHIBIT PASK | |
| EA201390332A1 (en) | DEUDIED PRIDOPIDINE ANALOGUES APPLICABLE AS DOPAMINER STABILIZERS | |
| UY32032A (en) | "2- [1-SUBSTITUTED-1H-PIRAZOLO [3,4-D] PIRIMIDIN-4-IL] (IO, OXI OR AMINO) -N- (HETEROARIL) ALCANAMIDS" | |
| EA201290865A1 (en) | APPLICATION OF LEVODOPA, CARBIDOPE AND ENTACAPON TO TREAT PARKINSON'S DISEASE | |
| EA201100245A1 (en) | NEW HOLIN SOKRISTALL EPALRESTAT | |
| EA201001287A1 (en) | TREATMENT OF HYPERGLYCEMIA 25-HYDROXIVITAMIN D3 | |
| ATE525084T1 (en) | USE OF AT LEAST ONE BOTULINUM NEUROTOXIN FOR THE TREATMENT OF PAIN RESULTING FROM THERAPEUTIC TREATMENTS FOR THE AIDS VIRUS | |
| EA200701750A1 (en) | IMPROVED PENOFIBRATE COMPOSITIONS CONTAINING MENTHOL OR PEG / POLOXAMER | |
| EA201100246A1 (en) | NEW BETAINE CRYSTAL EPALRESTAT | |
| Angulo et al. | Age-related differences in the effects of α and γ peroxisome proliferator-activated receptor subtype agonists on endothelial vasodilation in human microvessels | |
| EA201490045A1 (en) | DEUTERED 1-PIPERAZINO-3-PHENYLINDANES USED TO TREAT SCHIZOPHRENIA | |
| EA201391063A1 (en) | APOLIPOPROTEIN A-IV AS ANTIDIABETIC PEPTIDE | |
| EA200500313A1 (en) | DISINTOXICATION INFUSION SOLUTION | |
| IS7912A (en) | Use of docosahexenoic acid as an active agent for the treatment of lipodystrophy | |
| RU2006109966A (en) | YANTASTIM-S DRUG FOR THERAPY AND PREVENTION OF ANIMAL INFECTIOUS DISEASES | |
| BRPI0602179A (en) | pharmaceutical composition comprising cyclobenzaprine and aceclofenac in combination | |
| ATE489950T1 (en) | SOLUTION CONTAINING N-ACETYLCYSTEIN AND GLUCONIC ACID,AND METHOD FOR REDUCING, TREATING AND/OR PREVENTING OXIDATIVE STRESS AND CELL ACTIVATION | |
| NO20075943L (en) | Use of azithromycin for the manufacture of a medicament for the treatment of eye infections | |
| EA201401164A1 (en) | BALANCED INFUSION SOLUTION | |
| RU2005140708A (en) | METHOD FOR TREATING OSTEOARTHROSIS COMPLICATED BY REACT SYNOVITIS |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PC4A | Registration of transfer of a eurasian patent by assignment | ||
| QB4A | Registration of a licence in a contracting state | ||
| QB4A | Registration of a licence in a contracting state | ||
| QB4A | Registration of a licence in a contracting state | ||
| TK4A | Corrections in published eurasian patents | ||
| PC4A | Registration of transfer of a eurasian patent by assignment | ||
| QC4A | Termination of a registered licence in a contracting state |